A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS).

Clinical trial NCT04729751 · COMPLETED

Trial details

NCT number: NCT04729751
Sponsor: Mirum Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Progressive Familial Intrahepatic Cholestasis Alagille Syndrome Cholestatic Liver Disease

Start date: 2021-09-09
Primary completion: 2024-12-17
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.